Jed Sherwindt has joined Evercore Partners as a senior managing director in the firm’s San Francisco office. He previously was with Citigroup, as managing director and head of its global software I-banking group.
2 min read · 18 September 2008
Trillium Therapeutics Inc., a Toronto-based drug company focused on immune-mediated disorders has raised C$12 million in third-round funding. Return backers include VenGrowth Private Equity Partners, BDC Capital and Canadian Medical Discoveries Fund (CMDF).
2 min read · 18 September 2008
Mark Johnson, former vice chairman of CheckFree Corp., has joined Total Technology Ventures as a partner. TTV is an Atlanta-based firm focused on the financial services industry.
2 min read · 18 September 2008
Hollywood Interactive Group Inc., a producer of interactive content, has raised $5 million in Series A funding led by BlueRun Ventures. The company’s first project is MyHollywood.com, a “women’s web destination for celebrity and entertainment news, casual games, fashion and community.”
3 min read · 18 September 2008
Tethys Bioscience, an Emeryville, Calif.-based developer of multi-biomarker technology, has acquired Lipomics Technologies, a West Sacramento, Calif.-based developer of metabolite profiling technology. No financial terms were disclosed. Thethys has raised $54 million in total VC funding, from firms like Kleiner Perkins Caufield & Byers, Mohr Davidow Ventures, Intel Capital and DAG Ventures. Lipomics had raised an undisclosed amount of funding from firms like DFJ Frontier.
3 min read · 18 September 2008
ChemGenex Pharmaceuticals (Nasdaq: CXSP), an Australia-based oncology drug company, has raised A$12.9 million via a private share placement. It included an A$6.5 million investment by existing shareholders Alta Partners, GBS Venture Partners and Merck Santé.
3 min read · 18 September 2008
4 min read · 18 September 2008
4 min read · 18 September 2008
3 min read · 18 September 2008
WEbook.com, a Bethesda, Md.-based online platform for “crowd-sourcing” books, has raised more than $5 million in second-round funding. Vertex Venture Capital led the round, and was joined by return backer Greylock Partners Israel and individual angels.
4 min read · 18 September 2008